| 1 |
33099295 | Inhibition of MAPT enhances the effect of bexarotene and attenuates the damage after traumatic brain injury using in vivo and in vitro experiments. | 2020 |
1 |
| 2 |
29995422 | Retinoid X Receptor Alpha Nitro-ligand Z-10 and Its Optimized Derivative Z-36 Reduce β-Amyloid Plaques in Alzheimer's Disease Mouse Model. | 2019 Feb 4 |
1 |
| 3 |
31055081 | Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells. | 2019 Sep 1 |
1 |
| 4 |
31596896 | Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease. | 2019 |
2 |
| 5 |
27235741 | Bexarotene protects against traumatic brain injury in mice partially through apolipoprotein E. | 2017 Feb 20 |
2 |
| 6 |
27842487 | Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study. | 2017 |
2 |
| 7 |
28689412 | Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms. | 2017 Sep 20 |
2 |
| 8 |
26175148 | ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice. | 2016 Mar |
3 |
| 9 |
26688581 | Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1. | 2016 Mar |
3 |
| 10 |
27051978 | RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers. | 2016 Apr 7 |
1 |
| 11 |
25630951 | Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis. | 2015 Jun |
1 |
| 12 |
25777514 | The Continuing Failure of Bexarotene in Alzheimer's Disease Mice. | 2015 |
2 |
| 13 |
26085639 | Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. | 2015 Jun 17 |
1 |
| 14 |
24599963 | Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway. | 2014 Apr 18 |
4 |
| 15 |
24849361 | Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene. | 2014 May 21 |
1 |
| 16 |
25164224 | [Effects and related mechanism of retinoid X receptor agonist bexarotene on atherosclerosis progression in diabetic apoE(-/-) mice]. | 2014 Jun |
1 |
| 17 |
25217640 | Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. | 2014 Oct 31 |
3 |
| 18 |
23601557 | In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis. | 2013 Apr 19 |
1 |
| 19 |
23764200 | Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. | 2013 Jun 13 |
1 |
| 20 |
24047423 | New hope from an old drug: fighting Alzheimer's disease with the cancer drug bexarotene (targretin)? | 2013 Dec |
2 |
| 21 |
22323736 | ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. | 2012 Mar 23 |
1 |